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adapted if needed. 724 CT features were calculated using 
radiomics software. To test if features were different for 
EGFR+, KRAS+ or WT patients one way ANOVA (initially 
without correction for multiple testing) was performed using 
a 5% significance level. A pair-wise comparison (t-test) 
identified significantly different groups. 
 
Results: 51 EGFR+, 47 KRAS+ and 32 WT patients were 
included. 41 features were significantly different between 
EGFR+, KRAS+ and WT patients. One feature is a first order 
gray-level statistics feature (7% of feature subgroup total), 
two are gray-level co-occurrence matrix based (9%), two 
gray-level size-zone matrix based (18%), one Laplacian-of-
Gaussian transform based (0.5%) and 35 are wavelet 
transform based features (7%). Statistics for the significant 
features are shown in Table 1. One easy to interpret 
significantly different feature for EGFR+ compared to WT 
patients was the median Hounsfield Unit (HU). EGFR+ 
patients had a median HU which is on average 54±23 HU 
higher compared to WT patients, see Figure 1. KRAS+ 
patients did not have a significantly different median HU 
compared to EGFR+ or WT patients. 
 
 
 
 
Conclusion: We showed that there are differences in 
radiomic CT features between EGFR+, KRAS+ and WT NSCLC. 
The next step will be to externally validate (work in progress) 
a robust radiomic signature, based on standard CT imaging. 
Also this allows to monitor radiomic signature evolvement 
under treatment. 
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Hadron therapy is an advanced technique in the field of 
radiotherapy that makes use of charged particles such as 
protons and carbon ions. The inverted depth-dose profile and 
the sharp dose fall-off after the Bragg peak offered by 
charged particle beams allow for a more precise localization 
of the radiation dosage to the tumor as compared to the 
conventional used photons. As a consequence, the 
surrounding healthy tissue receives a much lower dose. 
Besides this ballistic advantage, the use of high-linear energy 
transfer (LET) carbon ion beams offers also a biological 
advantage, i.e. a higher relative biological effectiveness 
(RBE) as compared to conventional low-LET photon therapy.  
Carbon ion radiation is thus more effective in inducing DNA 
damage, cell cycle arrest and cell death, thereby accounting 
for highly lethal effects, even in tumors that are resistant to 
X-ray irradiation. 
The response of an irradiated cell depends on the dose, dose-
rate, radiation quality, the lapse between the radiation-
induced stress and the analysis, and the cell type. In this 
context, genome-wide studies can contribute in exploring 
differences in signaling pathways and to unravel 'high-LET-
specific' genes. Several studies within SCK•CEN and outside 
have already compared changes in gene expression induced 
by different radiation qualities. Overall, the number of 
differentially expressed genes as well as the magnitude of 
(dose-dependent) gene expression changes was found to be 
more pronounced after irradiation with particle beams.  
Currently, the Radiobiology Unit of SCK•CEN is deeply 
investigating the effect of low- and high-LET radiation on the 
gene expression of different cancer cell lines in vitro. Our 
results clearly demonstrate a dose-dependent downregulation 
in several genes involved in cell migration and motility after 
carbon ion irradiation. A higher number of genes as well as 
more pronounced changes in their expression levels were 
found after carbon ion irradiation compared to X-rays. 
Further research are currently investigating whether the 
observed molecular changes also influence the cellular 
'behavior' after irradiation in terms of cell migration and 
motility after irradiation, since these are prominent 
characteristics of cancer progression and metastasis. 
Assessing both the risks and advantages of high-LET 
irradiation can contribute to the study of the biological 
effect on the tumor and will lead to further acceptance and 
improvement of the clinical outcome of hadron therapy.  
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Particle therapy as cancer treatment, with either protons or 
heavier ions, provide a more favourable dose distribution 
compared to x-rays. While the physical characteristics of 
particle radiation have been the aim of intense research, less 
focus has been on the actual biological responses particle 
irradiation gives rise to. Protons and high LET radiation have 
a higher radiobiological effect (RBE), but RBE is a complex 
quantity, depending on both biological and physical 
parameters. One of the central questions in particle therapy 
is whether the tumor and the normal tissue has a differential 
RBE due to the difference in α/β ratio. Most of the data to 
enlighten this is in vitro data, and there is very limited in 
